Cuban drug used for lung cancer therapy may be used in Serbian clinical study

Cuban drug used for lung cancer therapy may be used in Serbian clinical study

In Serbia, a memorandum on the procurement of 1,680 units of the CimaVax-EGF vaccine has been signed between the Cuban CIMAB and the Serbian Institute of Virology, Vaccines and Sera Torlak, Serbia’s Ministry of Health said on its official website.
The provided quantities of the drug are sufficient for a full medical treatment for 30 cancer patients that will be part of a clinical study, considering that the drug has not yet been registered in Serbia or in the EU reports

source: Balkans.com

Our Facebook page Comments

Medlines

We are proud to announce that MEDLINES – Healthcare headlines started its’ very own blog site. Our mission is to bring the very best of the news and newsworthy issues of the medical field, from university news to business and tech info.

Leave a Reply

Close